Literature DB >> 1628538

Lead-induced cell proliferation and organ-specific tumorigenicity.

E J Calabrese1, L A Baldwin.   

Abstract

While lead acetate is a renal carcinogen in rodent studies, the mechanism by which it induces cancer has not been established. This report proposes that the enhanced susceptibility of renal tubular epithelial cells to lead-induced mitogenicity at the levels comparable to those administered in the cancer bioassay may contribute to the carcinogenic response seen in this target organ. Of relevance is that the nonresponsiveness of the liver to lead-induced carcinogenicity was associated with significantly less capacity (i.e., 675-fold) of lead to induce the mitogenic response in the rodent liver.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1628538     DOI: 10.3109/03602539208996299

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN: 0360-2532            Impact factor:   4.518


  4 in total

1.  Estimation of lead in biological samples of oral cancer patients chewing smokeless tobacco products by ionic liquid-based microextraction in a single syringe system.

Authors:  Sadaf S Arain; Tasneem G Kazi; Asma J Arain; Hassan I Afridi; Muhammad B Arain; Kapil D Brahman; Abdul H Panhwar; Mariam S Arain
Journal:  Environ Sci Pollut Res Int       Date:  2015-04-23       Impact factor: 4.223

2.  Analysis of Carcinogenic Heavy Metals in Gallstones and its Role in Gallbladder Carcinogenesis.

Authors:  Bikash Mondal; Dhrubajyoti Maulik; Mousumi Mandal; Gautam Narayan Sarkar; Sanjay Sengupta; Debidas Ghosh
Journal:  J Gastrointest Cancer       Date:  2017-12

3.  Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data.

Authors:  H Fu; P Boffetta
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

4.  Urinary Lead Concentration Is an Independent Predictor of Cancer Mortality in the U.S. General Population.

Authors:  Sen Li; Jiaxin Wang; Biao Zhang; Yuan Liu; Tao Lu; Yuanyuan Shi; Guangliang Shan; Ling Dong
Journal:  Front Oncol       Date:  2018-06-29       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.